Longeveron Inc.

NASDAQ: LGVN · Real-Time Price · USD
1.18
-0.01 (-0.84%)
At close: Jun 05, 2025, 3:59 PM
1.16
-1.29%
After-hours: Jun 05, 2025, 07:49 PM EDT
-0.84%
Bid 1.14
Market Cap 17.64M
Revenue (ttm) 2.23M
Net Income (ttm) -16.92M
EPS (ttm) -1.35
PE Ratio (ttm) -0.87
Forward PE -1.02
Analyst Buy
Ask 1.21
Volume 64,483
Avg. Volume (20D) 150,625
Open 1.22
Previous Close 1.19
Day's Range 1.17 - 1.23
52-Week Range 0.77 - 6.40
Beta 0.37

About LGVN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LGVN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LGVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 months ago
-0.65%
Longeveron shares are trading higher after the com... Unlock content with Pro Subscription
10 months ago
+0.87%
Longeveron shares are trading higher after the company announced study results from the CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer's disease, meeting its key objectives to advance data supporting a favorable benefit/risk profile.